http://www.pumabiotechnology.com
Puma Biotechnology, Inc. Company Intro
Puma Biotechnology, Inc is a development stage biopharmaceutical company dedicated to in-licensing and developing novel therapeutics for the treatment of cancer. Puma Biotechnology was founded by Alan H. Auerbach, who previously served as Founder, Chief Executive Officer and President of Cougar Biotechnology, Inc, a company dedicated to in-licensing and developing drugs for the treatment of cancer. Cougar was acquired by Johnson & Johnson in July 2009 for approximately $1 billion.
Industry
Healthcare
Puma Biotechnology, Inc. Headquaters
10880 Wilshire Boulevard
Los Angeles,90024
United States
Puma Biotechnology, Inc. Share price
26 Jan 2021 02:19 GMT
$11.15
0.01 (0.09 %)
Puma Biotechnology, Inc. Market cap
$499.018 M
WMC RANKING
2021
Puma Biotechnology, Inc. # 32
BiotechnologyLatest Puma Biotechnology, Inc. News
11 Jan 2021
Vaccine Adjuvant Market Growth & Key Futuristic By Products, Region And Trends Forecast to 2026 | SEPPIC Inc., Novavax, Inc., Hayashibara Co., Ltd., SPI Pharma Inc, Invivogen
Inc., Sigma Aldrich, Adjuatis, Vaxliant, Adjuvance Technologies, Inc., GlaxoSmithKline plc., Puma Biotechnology, Tj Kaiwei, Zhouyue, Aphios, and CSL Limited.
11 Jan 2021
Vaccine Adjuvant Market Growth & Key Futuristic By Products, Region And Trends Forecast to 2026 | SEPPIC Inc., Novavax, Inc., Hayashibara Co., Ltd., SPI Pharma Inc, Invivogen
Inc., Sigma Aldrich, Adjuatis, Vaxliant, Adjuvance Technologies, Inc., GlaxoSmithKline plc., Puma Biotechnology, Tj Kaiwei, Zhouyue, Aphios, and CSL Limited.
11 Jan 2021
Vaccine Adjuvant Market Growth & Key Futuristic By Products, Region And Trends Forecast to 2026 | SEPPIC Inc., Novavax, Inc., Hayashibara Co., Ltd., SPI Pharma Inc, Invivogen
Inc., Sigma Aldrich, Adjuatis, Vaxliant, Adjuvance Technologies, Inc., GlaxoSmithKline plc., Puma Biotechnology, Tj Kaiwei, Zhouyue, Aphios, and CSL Limited.
WMC Market Score
WMC Market to Revenue Score
Puma Biotechnology, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Puma Biotechnology, Inc. | USD | $235,475 | $223,687 | $-56,200 | $4,990M | 32 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $584,960B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $352,840B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $627,500B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,200B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Puma Biotechnology, Inc. Social Followers vs Top 4 Industry Competitors
Puma Biotechnology, Inc. Post vs Top 4 Industry Competitors
Puma Biotechnology, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Puma Biotechnology, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Puma Biotechnology, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Puma Biotechnology, Inc. | 2.55 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.54 | 29.44 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.37 | 100 | 60 | 0 | 0 | 90.05 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.77 | 86 | 0 | 0 | 99.30 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
